Subscribe to RSS
DOI: 10.1055/a-1961-2425
The Association of Prenatal C-Reactive Protein and Interleukin-8 Levels with Maternal Characteristics and Preterm Birth
Funding This work was supported by R01 HL091528 from National Health, Lung and Blood Institute (NHLBI) and UH3 OD023268 (NIH Office of the Director) to S.T.W. and A.A.L. R.N.F. is supported by UH3 OD023285. Y.-C.S.C. was supported by T-32 HL007427 and T-32 AI007306 from NHLBI. K.A.L.S. was supported by K08 from NHLBI (K08HL148178), and H.M. was supported by K01 from NHLBI (K01HL146977-01A1). R.S.K. was supported by K01 from NHLBI (K01 HL146980). H.K. was supported by the Jane and Aatos Erkko Foundation, the Paulo Foundation, and the Pediatric Research Foundation.Abstract
Objective The determinants of preterm birth remain unknown. Excessive maternal inflammation during pregnancy may play an important role in the pathogenesis of preterm birth. Our objective was to describe the association of prenatal levels of proinflammatory C-reactive protein (CRP) and interleukin-8 (IL-8) with preterm birth in participants of the Vitamin D Antenatal Asthma Reduction Trial.
Study Design Five hundred and twenty-eight patients with available samples of both first- and third-trimester plasma were included in this analysis. CRP and IL-8 were measured from maternal prenatal samples. We examined the association between prenatal CRP and IL-8 with maternal health characteristics and the outcome of preterm birth. We also described the patterns of change in CRP and IL-8 from first to third trimester and their association with preterm birth. A subgroup analysis comparing only those with a spontaneous preterm birth phenotype to those with term birth was also performed.
Results Maternal characteristics including lower educational attainment, higher prepregnancy body mass index, gestational diabetes, lower vitamin D, and an unhealthy diet were associated with elevated levels of prenatal CRP and IL-8. Higher third trimester CRP and an increase in CRP from first to third trimester were associated with an increased odds of preterm birth when compared to lower levels of CRP (adjusted odds ratio [aOR] = 1.49, 95% confidence interval: 1.02, 2.23, p = 0.04) or a decrease in CRP over pregnancy (aOR = 3.06, 95% CI = 1.31,7.55, p = 0.01), after adjusting for potential confounders. These associations were strengthened when comparing only patients with spontaneous preterm birth (n = 22) to those with term births.
Conclusion Higher levels of the proinflammatory markers CRP and IL-8 are associated with indicators of poor maternal health and preterm birth. Prenatal CRP levels may reflect maternal prenatal health status and serve as a predictor of preterm birth, especially among those with spontaneous preterm birth.
Key Points
-
Elevated prenatal CRP is associated with poor maternal health.
-
High prenatal CRP may predict premature birth, especially spontaneous premature birth phenotypes.
-
Vitamin D insufficiency may be a modifiable risk factor for prenatal inflammation.
* These authors contributed equally.
Publication History
Received: 27 January 2022
Accepted: 22 September 2022
Accepted Manuscript online:
14 October 2022
Article published online:
07 December 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Ashford KB, Chavan N, Ebersole JL. et al. Patterns of systemic and cervicovaginal fluid inflammatory cytokines throughout pregnancy. Am J Perinatol 2018; 35 (05) 455-462
- 2 Christian LM, Porter K. Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine 2014; 70 (02) 134-140
- 3 Szarka A, Rigó Jr. J, Lázár L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010; 11: 59
- 4 Cobo T, Jacobsson B, Kacerovsky M. et al. Systemic and local inflammatory response in women with preterm prelabor rupture of membranes. PLoS One 2014; 9 (01) e85277
- 5 Kalagiri RR, Carder T, Choudhury S. et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatol 2016; 33 (14) 1337-1356
- 6 Ashford K, Chavan NR, Wiggins AT. et al. Comparison of serum and cervical cytokine levels throughout pregnancy between preterm and term births. AJP Rep 2018; 8 (02) e113-e120
- 7 Ferguson KK, McElrath TF, Chen Y-H, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol 2014; 72 (03) 326-336
- 8 Sun L, Mao D, Cai Y. et al. Association between higher expression of interleukin-8 (IL-8) and haplotype -353A/-251A/+678T of IL-8 gene with preeclampsia: a case-control study. Medicine (Baltimore) 2016; 95 (52) e5537
- 9 Herrera-Muñoz A, Fernández-Alonso AM, Fischer-Suárez N, Chedraui P, Pérez-López FR. Maternal serum cytokine levels in pregnancies complicated with threatened preterm labour. Gynecol Endocrinol 2017; 33 (05) 408-412
- 10 Esplin MS. The importance of clinical phenotype in understanding and preventing spontaneous preterm birth. Am J Perinatol 2016; 33 (03) 236-244
- 11 Litonjua AA, Lange NE, Carey VJ. et al. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials 2014; 38 (01) 37-50
- 12 Rifas-Shiman SL, Willett WC, Lobb R, Kotch J, Dart C, Gillman MW. PrimeScreen, a brief dietary screening tool: reproducibility and comparability with both a longer food frequency questionnaire and biomarkers. Public Health Nutr 2001; 4 (02) 249-254
- 13 Savage JH, Lee-Sarwar KA, Sordillo JE. et al. Diet during pregnancy and infancy and the infant intestinal microbiome. J Pediatr 2018; 203: 47-54.e4
- 14 Fichorova RN, Richardson-Harman N, Alfano M. et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 2008; 80 (12) 4741-4751
- 15 Ersfeld DL, Rao DS, Body J-J. et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004; 37 (10) 867-874
- 16 Ashford KB, Hahn E, Hall L, Rayens MK, Noland M, Ferguson JE. The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes. J Obstet Gynecol Neonatal Nurs 2010; 39 (05) 525-535
- 17 Wei J, Liu C-X, Gong T-T, Wu Q-J, Wu L. Cigarette smoking during pregnancy and preeclampsia risk: a systematic review and meta-analysis of prospective studies. Oncotarget 2015; 6 (41) 43667-43678
- 18 Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017; 17 (08) 469-482
- 19 Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221 (01) 80-87
- 20 Vecchié A, Bonaventura A, Carbone F. et al. C-reactive protein levels at the midpregnancy can predict gestational complications. BioMed Res Int 2018; 2018: 1070151
- 21 Murphy VE, Namazy JA, Powell H. et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG 2011; 118 (11) 1314-1323
- 22 Gete DG, Waller M, Mishra GD. Effects of maternal diets on preterm birth and low birth weight: a systematic review. Br J Nutr 2020; 123 (04) 446-461
- 23 Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111 (12) 1805-1812
- 24 Takata S, Wada H, Tamura M. et al. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers 2011; 16 (06) 530-535
- 25 De Meeus JB, Pourrat O, Gombert J, Magnin G. C-reactive protein levels at the onset of labour and at day 3 post-partum in normal pregnancy. Clin Exp Obstet Gynecol 1998; 25 (1-2): 9-11
- 26 Mertens K, Muys J, Jacquemyn Y. Postpartum C-reactive protein: a limited value to detect infection or inflammation. Facts Views Vis ObGyn 2019; 11 (03) 243-250
- 27 Frevert CW, Goodman RB, Kinsella MG. et al. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J Immunol 2002; 168 (07) 3550-3556
- 28 Mirzakhani H, Carey VJ, McElrath TF. et al. The association of maternal asthma and early pregnancy vitamin d with risk of preeclampsia: an observation from Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol Pract 2018; 6 (02) 600-608.e2
- 29 Yadama AP, Mirzakhani H, McElrath TF, Litonjua AA, Weiss ST. Transcriptome analysis of early pregnancy vitamin D status and spontaneous preterm birth. PLoS One 2020; 15 (01) e0227193
- 30 Mirzakhani H, Litonjua AA, McElrath TF. et al. Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 2016; 126 (12) 4702-4715
- 31 Nikbakht R, Moghadam EK, Nasirkhani Z. Maternal serum levels of C-reactive protein at early pregnancy to predict fetal growth restriction and preterm delivery: A prospective cohort study. Int J Reprod Biomed (Yazd) 2020; 18 (03) 157-164
- 32 Qin L-L, Lu F-G, Yang S-H, Xu H-L, Luo B-A. Does maternal vitamin D deficiency increase the risk of preterm birth: a meta-analysis of observational studies. Nutrients 2016; 8 (05) E301
- 33 Purswani JM, Gala P, Dwarkanath P, Larkin HM, Kurpad A, Mehta S. The role of vitamin D in pre-eclampsia: a systematic review. BMC Pregnancy Childbirth 2017; 17 (01) 231
- 34 Mazidi M, Rezaie P, Vatanparast H. Impact of vitamin D supplementation on C-reactive protein; a systematic review and meta-analysis of randomized controlled trials. BMC Nutr 2018; 4 (01) 1